access to the successful heavy metals
chelator, NBMI, by Emeramed.
The product is NBMI which has had several name changes and was known and Irminix, OSR and a few other names. It is all the same product and it has those sick from metals poisoning waiting to be able to access it.
FDA access has been a lengthy process which has driven many to use counterfeit products. These products made by others are sold on line and simply are not NBMI. In many cases the counterfeit manufacturer has the consumer sign a waiver stating they are aware that the product is not for human or animal consumption. Actual NMBI will have no such warning.
It is possible to access NBMI via the FDA process, but availability depends on the regulations in your area. In some areas it is very easy and in others it can take time.
We now have another possible route to obtaining this product that clears metals without the usual side effects or danger to the body. In May of 2018 the Right to Try Act was signed in the United States. It gives critically ill patients the right to try drugs that are in trials within the Food and Drug Administration. Thirty seven states have adopted the law on a state level. With or without state adoption of the Right to Try Act you are able to utilize the law, as state approval is not necessary.
Because the law is new not everything is known about how it will function or what will be approved. Things that are known for sure are:
- Although there may be a charge for obtaining the drug, the drug itself will be free.
- You must have a life threatening condition.
- You must have exhausted other options.
- You must not be able to qualify for trials as certified by a doctor.
- You must have informed consent of any potential risks.
Emeramed’s NBMI was on the market several years ago as a dietary antioxidant. It proved a very effective chelator of metals with an affinity for mercury. It crosses the blood brain barrier and clears the body of metals without painful side effects.
Once NMBI chelates to metal, it becomes inert and unable to harm the body. It will not drop the metal before it exits the body which prevents it from reabsorbing into tissue, organs, bones and brain. The chelated metal exits the body via the colon and not the kidneys, thereby preventing damage to organs. There are no known side effects to this product.
The focus of testing NBMI has been done with mercury. All results are positive for it's ability to chelate and remove the metal. It manages other metals as well, but has an affinity for removing mercury first. Because it crosses the blood-brain barrier, it clears the brain of metal and has shown success with Alzheimer’s patients, although it is not yet in trials for that particular use. Another area of success is COPD which can be an accumulation of cadmium in the lungs. Patients who have used NBMI for this purpose have experienced great improvement in very short time periods.
The US Army is considering testing of NMBI on mustard gas toxicity. The governments of Ecuador and Columbia have successfully used it on gold miners who use mercury to separate materials while mining. The success rate was overwhelming.
Currently NBMI is not available in the US without special authorization from the FDA. Some countries have allowed its use and others provide very simple access to NBMI. The links below will take you to the application form for Emeramed’s site to the FDA’s Compassionate Use application and another to the federal application for the Right to Try Act.
Right to Try Act